Medicine and Health

Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice

A. S. Ashhurst, M. D. Johansen, et al.

Current vaccines against SARS-CoV-2 significantly reduce mortality, but infection protection remains inadequate. This research, conducted by Anneliese S Ashhurst and colleagues, explores a novel mucosal subunit vaccine that enhances respiratory tract immunity, promising better defense against the virus and minimizing viral spread.

00:00

Playback language: English

Related Publications

Explore these studies to deepen your understanding of the subject.

Medicine and Health

Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice

A. A. Ordonez, C. K. Bullen, et al.

Medicine and Health

SARS-CoV-2 vaccination, booster, and infection in pregnant population enhances passive immunity in neonates

E. A. Murphy, C. Guzman-cardozo, et al.

Medicine and Health

A Gamma-adapted subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from infection

L. M. Coria, J. M. Rodriguez, et al.

Medicine and Health

SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals

K. Sano, D. Bhavsar, et al.

Listen, Learn & Level Up

Over 10,000 hours of research content in 25+ fields, available in 12+ languages.

No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.

listen to research audio papers with researchbunny